Interleukin-2 serum levels are elevated in patients with uremic pruritus: A novel finding with practical implications

Nephrology Dialysis Transplantation

Volumn 26, Issue 10, 2011, Pages 3338-3344

  Fallahzadeh, Mohammad Kazem ^a   Roozbeh, Jamshid ^b   Geramizadeh, Bita ^a   Namazi, Mohammad Reza ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dialysis; Inflammation; Skin; T lymphocytes; Uraemic pruritus

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; FERRITIN; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 2; INTERLEUKIN 4; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PRURITUS; TH1 TH2 BALANCE; UREMIC PRURITUS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PRURITUS; RENAL DIALYSIS; TH1 CELLS; TH2 CELLS; UREMIA; YOUNG ADULT;

EID: 80051646638     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr053     Document Type: Article

References (45)

1. Kuypers DR. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 2009; 5: 157-170
2. Hampers CL, Katz AI, Wilson RE et al. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med 1968; 279: 695-697
3. Narita I, Alchi B, Omori K et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006; 69: 1626-1632
4. Friga V, Linos A, Linos DA. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients? Nephron 1997; 75: 48-53 (Pubitemid 27052937)
5. Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 1985; 23: 285-288 (Pubitemid 15059838)
6. De Marchi S, Cecchin E, Villalta D et al. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326: 969-974
7. Umeuchi H, Togashi Y, Honda T et al. Involvement of central muopioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol 2003; 477: 29-35 (Pubitemid 38366082)
8. Kimmel M, Alscher DM, Dunst R et al. The role of microinflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 749-755 (Pubitemid 43378900)
9. Chiu YL, Chen HY, Chuang YF et al. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 3685-3689
10. Cho YL, Liu HN, Huang TP et al. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997; 36: 538-543
11. Virga G, Visentin I, La Milia V et al. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 2164-2169 (Pubitemid 35446673)
12. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793 (Pubitemid 26372655)
13. Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs 1989; 12:411-419 (Pubitemid 19185306)
14. Duo LJ. Electrical needle therapy of uremic pruritus. Nephron 1987; 47: 179-183 (Pubitemid 17148000)
15. Mettang T, Fritz P, Weber J et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34: 136-141 (Pubitemid 20295708)
16. Hiroshige K, Kabashima N, Takasugi M et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413-419
17. Pisoni RL, Wikstrom B, Elder SJ et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505 (Pubitemid 44817100)
18. Chou FF, Ho JC, Huang SC et al. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 2000; 190: 65-70
19. Duque MI, Yosipovitch G, Fleischer AB Jr et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 2005; 52: 519-521
20. Lin HH, Liu YL, Liu JH et al Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs 2008; 32: 468-472
21. Gilchrest BA, Rowe JW, Brown RS et al. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 1979; 91:17-21 (Pubitemid 9244627)
22. Garssen J, Vandebriel RJ, De Gruijl FR et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 1999; 97: 506-514 (Pubitemid 29314649)
23. Pauli-Magnus C, Klumpp S, Alscher DM et al. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Petit Dial Int 2000; 20 : 802-803
24. Kuypers DR, Claes K, Evenepoel P et al. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004; 19: 1895-1901 (Pubitemid 38961406)
25. Silva SR, Viana PC, Lugon NV et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67: 270-273 (Pubitemid 24177633)
26. McHugh SM, Rifkin IR, Deighton J et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits ThI cytokine production in mitogen- and antigenstimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99: 160-167
27. Altmeyer P, Kachel HG, Schafer G et al. [Normalization of uremic skin changes following kidney transplantation]. Hautarzt 1986; 37: 217-221
28. Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007; 127: 1857-1859 (Pubitemid 47075372)
29. Wahlgren CF, Tengvall Linder M, Hagermark O et al. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-580
30. Darsow U, Scharein E, Bromm B et al. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction. Br J Dermatol 1997; 137: 415-417 (Pubitemid 27421571)
31. Gaspari AA, Lotze MT, Rosenberg SA et al. Dermatologie changes associated with interleukin 2 administration. JAMA 1987; 258: 1624-1629 (Pubitemid 17138454)
32. Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 2003; 149: 718-730 (Pubitemid 37411991)
33. Mathur VS, Lindberg J, Germain M et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 1410-1419
34. Prinz M, Rossum DV, Hanisch U-K. Interleukin-2 as a neuroregulatory cytokine. In: Phelps C, Korneva E. (eds). Neurolmmune Biology, Vol. 6: Cytokines and the Brain. Elsevier, Amsterdam, The Netherlands: 2008; 145-165
35. Steinhoff M, Bienenstock J, Schmelz M et al. Neurophysiologies, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006; 126: 1705-1718 (Pubitemid 44102116)
36. Jiang CL, Xu D, Lu CL et al. Interleukin-2: structural and biological relatedness to opioid peptides. Neuroimmunomodulation 2000; 8: 20-24 (Pubitemid 30407568)
37. Song P, Lie-Cheng W, Wang GD et al. Interleukin-2 regulates membrane potentials and calcium channels via mu opioid receptors in rat dorsal root ganglion neurons. Neuropharmacology 2002; 43: 1324-1329
38. Gu J, Yao M, Wang J et al. Suppression of morphine withdrawal syndrome by interleukin-2 and its gene. Neuroreport 2005; 16: 387-391 (Pubitemid 40434571)
39. Onigbogi O, Ajayi AA, Ukponmwan OE. Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides. Pharmacol Biochem Behav 2000; 65: 333-337 (Pubitemid 30100281)
40. Lugon JR. Uremic pruritus: a review. Hemodial Int 2005; 9: 180-188 (Pubitemid 40940994)
41. Peer G, Kivity S, Agami O et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348: 1552-1554
42. Pauli-Magnus C, Mikus G, Alscher DM et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000; 11: 514-519 (Pubitemid 30115081)
43. Chen HY, Chiu YL, Hsu SP et al. Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM 2010; 103: 837-846
44. Sethi D, Muller BR, Brown EA et al. C-reactive protein in haemodialysis patients with dialysis arthropathy. Nephrol Dial Transplant 1988; 3: 269-271
45. Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y et al. Altered Thl/Th2 commitment in human CD4- T cells with ageing. Clin Exp Immunol 2000; 120: 267-273 (Pubitemid 30304221)